OS1.5 Harnessing soluble LRIG1 for pan-RTK targeting in glioblastoma

INTRODUCTION: The role of receptor tyrosine kinases (RTKs) in glioblastoma is widely acknowledged. However, therapies based on RTK targeting have been continuously unsuccessful in GBM patients, highlighting the complexity of RTK signaling and biology. LRIG1 (Leucine-rich Repeats and ImmunoGlobulin d...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Neirinckx, V, Schuster, A, Chevigné, A, Schmidt, M H H, Niclou, S P
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Oral Presentations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144038/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller